Orvosi Hetilap
Volume/Issue:
Volume 152: Issue 38
Fatty liver and hepatitis C virus infection
Authors: Marianna Lakatos 1 , Krisztina Hagymási 2 , and Gabriella Lengyel 2
View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar Budapest
  • 2 Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088
DOI:
https://doi.org/10.1556/oh.2011.29209
Page Count:
1513–1519
Publication Date:
01 Sep 2011
Online Publication Date:
06 Sep 2011
Article Category:
Research Article
Open access

A hepatitis C-vírus-fertőzés világszerte gyakori megbetegedés, amely májzsírosodás, cirrhosis és májrák kialakulásához vezet. Idült hepatitis C-vírus-fertőzöttek mintegy 55%-ában mutatható ki a máj változó mértékű elzsírosodása, amelynek hátterében részben anyagcsere- (metabolikus), részben víruseredetű tényezők állnak. A vírus magfehérjéje számos sejten belüli jelátviteli utat befolyásol. A folyamatok pontos megértése jelenleg is kutatások tárgya. Az elhízás és az inzulinrezisztencia a vírusellenes kezelésre adott választ rontja. A közlemény célja a steatosis hepatis, valamint az inzulinrezisztencia és a kombinált antivirális terápiára adott válasz közötti összefüggés áttekintése idült C-vírus hepatitisben. Orv. Hetil., 2011, 152, 1513–1519.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Kahn, M., Jahan, S., Khaliq, S. és mtsai: Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. Arch. Virol., 2010, 155, 1735–1753.

    Khaliq S. , 'Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis ' (2010 ) 155 Arch. Virol. : 1735 -1753.

    • Search Google Scholar

  • Rodriguez-Luna, H., Vargas, H. E.: Management of hepatitis C virus infection in the setting of liver transplantation. Liver Transpl., 2005, 11, 479–489.

    Vargas H. E. , 'Management of hepatitis C virus infection in the setting of liver transplantation ' (2005 ) 11 Liver Transpl. : 479 -489.

    • Search Google Scholar

  • Hagymási K., Fehér J.: A testsúlycsökkentés hatása a kombinált interferon-alfa-2a + ribavirin kezelésre adott válaszra idült HCV hepatitisben. Orv. Hetil., 2008, 149, 2189–2192.

    Fehér J. , 'A testsúlycsökkentés hatása a kombinált interferon-alfa-2a + ribavirin kezelésre adott válaszra idült HCV hepatitisben ' (2008 ) 149 Orv. Hetil. : 2189 -2192.

    • Search Google Scholar

  • Alaei, M., Negro, F.: Hepatitis C virus and glucose and lipid metabolism. Diabetes Metab., 2008, 34, 692–700.

    Negro F. , 'Hepatitis C virus and glucose and lipid metabolism ' (2008 ) 34 Diabetes Metab. : 692 -700.

    • Search Google Scholar

  • Browning, J. D., Szczepaniak, L. S., Dobbins, R. és mtsai: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology, 2004, 40, 1387–1395.

    Dobbins R. , 'Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity ' (2004 ) 40 Hepatology : 1387 -1395.

    • Search Google Scholar

  • Bellentani, S., Saccoccio, G., Masutti, F. és mtsai: Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med., 2000, 132, 112–117.

    Masutti F. , 'Prevalence of and risk factors for hepatic steatosis in Northern Italy ' (2000 ) 132 Ann. Intern. Med. : 112 -117.

    • Search Google Scholar

  • Persico, M., Iolascon, A.: Steatosis as a co-factor in chronic liver diseases. Word J. Gastroenterol., 2010, 16, 1171–1176.

    Iolascon A. , 'Steatosis as a co-factor in chronic liver diseases ' (2010 ) 16 Word J. Gastroenterol. : 1171 -1176.

    • Search Google Scholar

  • Lonardo, A., Loria, P., Adinolfi, L. E. és mtsai: Hepatitis C and steatosis: a reappraisal. J. Viral. Hepat., 2006, 13, 73–80.

    Adinolfi L. E. , 'Hepatitis C and steatosis: a reappraisal ' (2006 ) 13 J. Viral. Hepat. : 73 -80.

    • Search Google Scholar

  • Werling, K., Schaff, Zs., Dinya, E. és mtsa: Effect of liver steatosis on therapautic response in chronic hepatitis C virus genotype 1 infected patients in Hungary. Pathol. Oncol. Res., 2010, 16, 149–157.

    Dinya E. , 'Effect of liver steatosis on therapautic response in chronic hepatitis C virus genotype 1 infected patients in Hungary ' (2010 ) 16 Pathol. Oncol. Res. : 149 -157.

    • Search Google Scholar

  • Jármay, K., Karácsony, G., Nagy, A. és mtsa: Changes in lipid metabolism in chronic hepatitis C. Word J. Gastroenterol., 2005, 11, 6422–6428.

    Nagy A. , 'Changes in lipid metabolism in chronic hepatitis C ' (2005 ) 11 Word J. Gastroenterol. : 6422 -6428.

    • Search Google Scholar

  • Kapadia, S. B., Barth, H., Baumert, T. és mtsai: Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol., 2007, 81, 374–383.

    Baumert T. , 'Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I ' (2007 ) 81 J. Virol. : 374 -383.

    • Search Google Scholar

  • Del Campo, J. A., Romero-Gomez, M.: Steatosis and insulin resistance in hepatitis C: A way out for the virus? Word J. Gastroenterol., 2009, 15, 5014–5019.

    Romero-Gomez M. , 'Steatosis and insulin resistance in hepatitis C: A way out for the virus? ' (2009 ) 15 Word J. Gastroenterol. : 5014 -5019.

    • Search Google Scholar

  • Jhaveri, R., McHutchison, J., Patel, K. és mtsai: Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation. J. Infect. Dis., 2008, 197, 283–291.

    Patel K. , 'Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation ' (2008 ) 197 J. Infect. Dis. : 283 -291.

    • Search Google Scholar

  • Rubbia-Brandt, L., Quadri, R., Abid, K. és mtsai: Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J. Hepatol., 2000, 33, 106–115.

    Abid K. , 'Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 ' (2000 ) 33 J. Hepatol. : 106 -115.

    • Search Google Scholar

  • Adinolfi, L. E., Gambardella, M., Andreana, A. és mtsai: Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology, 2001, 33, 1358–1364.

    Andreana A. , 'Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity ' (2001 ) 33 Hepatology : 1358 -1364.

    • Search Google Scholar

  • De Gotthardi, A., Pazienzi, V., Pugnale, P. és mtsai: Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection. Aliment. Pharmacol. Ther., 2006, 23, 107–114.

    Pugnale P. , 'Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection ' (2006 ) 23 Aliment. Pharmacol. Ther. : 107 -114.

    • Search Google Scholar

  • Yoneda, M., Saito, S., Ikeda, T. és mtsai: Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J. Viral. Hepat., 2007, 14, 600–607.

    Ikeda T. , 'Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients ' (2007 ) 14 J. Viral. Hepat. : 600 -607.

    • Search Google Scholar

  • Moucari, R., Asselah, T., Cazals-Hatem, D. és mtsai: Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology, 2008, 134, 416–423.

    Cazals-Hatem D. , 'Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis ' (2008 ) 134 Gastroenterology : 416 -423.

    • Search Google Scholar

  • Kumar, D., Farrell, G. C., Fung, C. és mtsa: Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response. Hepatology, 2002, 36, 1266–1272.

    Fung C. , 'Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response ' (2002 ) 36 Hepatology : 1266 -1272.

    • Search Google Scholar

  • Tsai, W-L., Chung, R. T.: Viral hepatocarcinogenesis. Oncogene, 2010, 29, 2309–2324.

    Chung R. T. , 'Viral hepatocarcinogenesis ' (2010 ) 29 Oncogene : 2309 -2324.

  • Hofer, H., Bankl, H. C., Wrba, F. és mtsai: Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am. J. Gastroenterol., 2002, 93, 2880–2885.

    Wrba F. , 'Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a ' (2002 ) 93 Am. J. Gastroenterol. : 2880 -2885.

    • Search Google Scholar

  • Mirandola, S., Realdon, S., Iqbal, J. és mtsai: Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology, 2006, 130, 1661–1669.

    Iqbal J. , 'Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis ' (2006 ) 130 Gastroenterology : 1661 -1669.

    • Search Google Scholar

  • Shimano, H., Horton, J. D., Shimomura, I. és mtsai: Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J. Clin. Invest., 1997, 99, 846–854.

    Shimomura I. , 'Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells ' (1997 ) 99 J. Clin. Invest. : 846 -854.

    • Search Google Scholar

  • Bajnok L., Paragh Gy.: Lipid modulált transzkripciós faktorok szerepe az energiaháztartás szabályozásában. Metabolizmus, 2003, 4, 192–198.

    Paragh Gy. , 'Lipid modulált transzkripciós faktorok szerepe az energiaháztartás szabályozásában ' (2003 ) 4 Metabolizmus : 192 -198.

    • Search Google Scholar

  • Tontonoz, P., Hu, E., Spiegelman, B. M.: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell, 1994, 79, 1147–1156.

    Spiegelman B. M. , 'Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor ' (1994 ) 79 Cell : 1147 -1156.

    • Search Google Scholar

  • Kapadia, S. B., Chisari, F. V.: Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc. Natl. Acad. Sci. USA, 2005, 102, 2561–2566.

    Chisari F. V. , 'Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids ' (2005 ) 102 Proc. Natl. Acad. Sci. USA : 2561 -2566.

    • Search Google Scholar

  • Moradpour, D., Penin, F., Rice, C. M.: Replication of hepatitis C virus. Nat. Rev. Microbiol., 2007, 5, 453–463.

    Rice C. M. , 'Replication of hepatitis C virus ' (2007 ) 5 Nat. Rev. Microbiol. : 453 -463.

  • Barba, G., Harper, F., Harada, T. és mtsai: Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA, 1997, 94, 1200–1205.

    Harada T. , 'Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets ' (1997 ) 94 Proc. Natl. Acad. Sci. USA : 1200 -1205.

    • Search Google Scholar

  • Shavinskaya, A., Boulant, S., Penin, F. és mtsai: The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J. Biol. Chem., 2007, 282, 37158–37169.

    Penin F. , 'The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly ' (2007 ) 282 J. Biol. Chem. : 37158 -37169.

    • Search Google Scholar

  • McLauchlan, J., Lemberg, M. K., Hope, G. és mtsa: Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J., 2002, 21, 3980–3988.

    Hope G. , 'Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets ' (2002 ) 21 EMBO J. : 3980 -3988.

    • Search Google Scholar

  • Appel, N., Zayas, M., Miller, S. és mtsai: Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog., 2008, 4, e1000035.

    Miller S. , 'Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly ' (2008 ) 4 PLoS Pathog. : e1000035 -.

    • Search Google Scholar

  • Nahmias, Y., Goldwasser, J., Casali, M.: Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology, 2008, 47, 1437–1445.

    Casali M. , 'Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin ' (2008 ) 47 Hepatology : 1437 -1445.

    • Search Google Scholar

  • Wang, T., Campbell, R. V., Yi, M. K.: Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction. J. Viral Hepat., 2010, 17, 784–793.

    Yi M. K. , 'Role of hepatitis C virus core protein in viral-induced mitochondrial dysfunction ' (2010 ) 17 J. Viral Hepat. : 784 -793.

    • Search Google Scholar

  • Gong, G., Waris, G., Tanveer, R. és mtsa: Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. USA, 2001, 98, 9599–9604.

    Tanveer R. , 'Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B ' (2001 ) 98 Proc. Natl. Acad. Sci. USA : 9599 -9604.

    • Search Google Scholar

  • Lin, W., Tsai, W. L., Shao, R. X. és mtsai: Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappa B-dependent manner. Gastroenterology, 2010, 138, 2509–2518.

    Shao R. X. , 'Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappa B-dependent manner ' (2010 ) 138 Gastroenterology : 2509 -2518.

    • Search Google Scholar

  • Moriya, K., Miyoshi, H., Shinzawa, S.: Hepatitis C virus core protein compromises iron-induced activation of antioxidants in mice and HepG2 cells. J. Med. Virol., 2010, 82, 776–792.

    Shinzawa S. , 'Hepatitis C virus core protein compromises iron-induced activation of antioxidants in mice and HepG2 cells ' (2010 ) 82 J. Med. Virol. : 776 -792.

    • Search Google Scholar

  • El-Zayadi, A. R.: Hepatic steatosis: A benign disease or a silent killer. Word J. Gastroenterol., 2008, 14, 4120–4126.

    El-Zayadi A. R. , 'Hepatic steatosis: A benign disease or a silent killer ' (2008 ) 14 Word J. Gastroenterol. : 4120 -4126.

    • Search Google Scholar

  • Harrison, S. A.: Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment. Clin. Gastroenterol. Hepatol., 2008, 6, 864–876.

    Harrison S. A. , 'Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment ' (2008 ) 6 Clin. Gastroenterol. Hepatol. : 864 -876.

    • Search Google Scholar

  • Negro, F.: Mechanisms and significance of liver steatosis in hepatitis C virus infection. Word J. Gastroenterol., 2006, 12, 6756–6765.

    Negro F. , 'Mechanisms and significance of liver steatosis in hepatitis C virus infection ' (2006 ) 12 Word J. Gastroenterol. : 6756 -6765.

    • Search Google Scholar

  • Arrese, M., Riquelme, A., Soza, A.: Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with releant clinical implications. Ann. Hepatol., 2010, 9 (Suppl.), 112–118.

    Soza A. , 'Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with releant clinical implications ' (2010 ) 9 Ann. Hepatol. : 112 -118.

    • Search Google Scholar

  • Bach, N., Thung, S. N., Schaffner, F.: The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology, 1997, 15, 572–577.

    Schaffner F. , 'The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis ' (1997 ) 15 Hepatology : 572 -577.

    • Search Google Scholar

  • Im, S. S., Kwon, S. K., Kim, T. H. és mtsa: Regulation of glucose transporter type 4 isoform gene expression in muscle and adipocytes. IUBMB Life, 2007, 185, 153–161.

    Kim T. H. , 'Regulation of glucose transporter type 4 isoform gene expression in muscle and adipocytes ' (2007 ) 185 IUBMB Life : 153 -161.

    • Search Google Scholar

  • Maeda, K., Okubo, K., Shimomura, I. és mtsai: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun., 1996, 221, 286–289.

    Shimomura I. , 'cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) ' (1996 ) 221 Biochem. Biophys. Res. Commun. : 286 -289.

    • Search Google Scholar

  • Wolf, A. M., Wolf, D., Rumpold, H. és mtsai: Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun., 2004, 323, 630–635.

    Rumpold H. , 'Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes ' (2004 ) 323 Biochem. Biophys. Res. Commun. : 630 -635.

    • Search Google Scholar

  • Wedemeyer, I., Bechmann, L. P., Odenthal, M. és mtsai: Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C. J. Hepatol., 2009, 50, 140–149.

    Odenthal M. , 'Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C ' (2009 ) 50 J. Hepatol. : 140 -149.

    • Search Google Scholar

  • Pazienza, V., Clement, S., Pugnale, P. és mtsai: The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology, 2007, 45, 1164–1171.

    Pugnale P. , 'The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms ' (2007 ) 45 Hepatology : 1164 -1171.

    • Search Google Scholar

  • Persico, M., Capasso, M., Persico, E. és mtsai: Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy. Hepatology, 2007, 46, 1009–1015.

    Persico E. , 'Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy ' (2007 ) 46 Hepatology : 1009 -1015.

    • Search Google Scholar

  • Sanyal, A. J.: Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C. Liver Int., 2011, 31 (Suppl. 1), 23–28.

    Sanyal A. J. , 'Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C ' (2011 ) 31 Liver Int. : 23 -28.

    • Search Google Scholar

  • Romero-Gomez, M., Del Mar Viloria, M., Andrade, R. J. és mtsai: Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology, 2005, 128, 636–641.

    Andrade R. J. , 'Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients ' (2005 ) 128 Gastroenterology : 636 -641.

    • Search Google Scholar

  • Bressler, B. L., Guindi, M., Tomlinson, G. és mtsa: High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C. Hepatology, 2003, 38, 639–644.

    Tomlinson G. , 'High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C ' (2003 ) 38 Hepatology : 639 -644.

    • Search Google Scholar

  • Giannini, E., Ceppa, P., Testa, R.: Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? J. Hepatol., 2001, 35, 432–433.

    Testa R. , 'Steatosis in chronic hepatitis C: can weight reduction improve therapeutic efficacy? ' (2001 ) 35 J. Hepatol. : 432 -433.

    • Search Google Scholar

  • Banerjee, D., Williams, E. V., Ilott, J. és mtsai: Obesity predisposes to increased drainage following axillary node clearance: a prospective audit. Ann. R. Coll. Surg. Engl., 2001, 83, 268–271.

    Ilott J. , 'Obesity predisposes to increased drainage following axillary node clearance: a prospective audit ' (2001 ) 83 Ann. R. Coll. Surg. Engl. : 268 -271.

    • Search Google Scholar

  • Walsh, M. J., Jonsson, J. R., Richardson, M. M. és mtsai: Nonresponse to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut, 2006, 55, 529–535.

    Richardson M. M. , 'Nonresponse to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1 ' (2006 ) 55 Gut : 529 -535.

    • Search Google Scholar

  • Suwantarat, N., Tice, A. D., Khawcharoenporn, T. és mtsa: Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to hepatitis C treatment. Int. J. Med. Sci., 2010, 7, 36–42.

    Khawcharoenporn T. , 'Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to hepatitis C treatment ' (2010 ) 7 Int. J. Med. Sci. : 36 -42.

    • Search Google Scholar
Cover Orvosi Hetilap
Orvosi Hetilap
Print ISSN:
0030-6002
Online ISSN:
1788-6120
Keywords:
hepatitis C-vírus; steatosis; inzulinrezisztencia; antivirális kezelés; hepatitis C virus; steatosis; insulin resistance; antiviral treatment

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Sep 2020 0 4 0
Oct 2020 0 5 1
Nov 2020 0 13 3
Dec 2020 0 4 2
Jan 2021 0 5 2
Feb 2021 0 6 8
Mar 2021 0 2 1